TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31829245

Group type: EXPERIMENTAL
Intervention: Topical‐TXA
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: IV‐TXA
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control
Number of subjects: 207
Study: 30032218

Group type: EXPERIMENTAL
Intervention: Randomized trials in nutrition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pivotal megatrials with tens of thousands of participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct observation of participants in experimental in-house settings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Registry-based designs and 'N-of-1' designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization designs
Number of subjects: 0
Study: 27031610

Group type: EXPERIMENTAL
Intervention: Low-intensity running three times a week (exercise intervention)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Wait list (no intervention)
Number of subjects: 97
Study: 25041227

Group type: EXPERIMENTAL
Intervention: Low-exposure everolimus (3–6 ng/mL) with reduced-exposure cyclosporine (n=56)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard-exposure cyclosporine (n=59)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Low-exposure everolimus
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard-exposure cyclosporine
Number of subjects: 115
Study: 22093233

Group type: EXPERIMENTAL
Intervention: HIFU at 47 J/cm²
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: HIFU at 52 J/cm²
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: HIFU at 59 J/cm²
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: All treatment groups combined
Number of subjects: 141
Study: 19606455

Group type: EXPERIMENTAL
Intervention: Case Management (CM) by a trained occupational therapist for 4 months
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care only (Control group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Case Management (CM)
Number of subjects: 102
Study: 22299599

Group type: EXPERIMENTAL
Intervention: Ethinylestradiol/levonorgestrel combined oral contraceptive (20 µg ethinylestradiol/100 µg levonorgestrel) for 21 days
Number of subjects: 34
Study: 15662209

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 341
Study: 12424652

Group type: EXPERIMENTAL
Intervention: Intensive and adaptive training of working memory (WM) tasks
Number of subjects: 0
Study: 10751841

Group type: EXPERIMENTAL
Intervention: Topical acne treatments
Number of subjects: 0
Study: 8759897

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b (IFN alpha)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no IFN alpha)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Low-risk observation group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Overall Survival (OS) for IFN alpha group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Overall Survival (OS) for control group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Overall Survival (OS) for low-risk group
Number of subjects: 99
Study: 2007888

Group type: EXPERIMENTAL
Intervention: Brief dynamic psychotherapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Therapist interventions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 32
Study: 7096960

Group type: EXPERIMENTAL
Intervention: Paromomycin sulfate 2 g/day for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Paromomycin sulfate
Number of subjects: 24
Study: 29428536

Group type: COMPARATOR
Intervention: Foam Sclerotherapy (FS) alone
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Ligation after Foam Sclerotherapy (FSL)
Number of subjects: 182
Study: 27038920

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 100 mg every 8 hours for 7 days or until shock reversal
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo every 8 hours for 7 days or until shock reversal
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 100 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 100 mg in patients with baseline cortisol < 15 ug/dL
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo in patients with baseline cortisol < 15 ug/dL
Number of subjects: 50
Study: 25712437

Group type: EXPERIMENTAL
Intervention: 0.1% topical tacrolimus (Tcr)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1% cyclosporine A (Cyc)
Number of subjects: 30
Study: 24403197

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team (nephrologist, nurse, psychologist, social worker)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine team (nephrologist and nurse)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team
Number of subjects: 40
Study: 20395952

Group type: EXPERIMENTAL
Intervention: Obesity curriculum on controllable reasons for obesity (diet/exercise)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Prejudice reduction condition presenting evidence on uncontrollable reasons for obesity (genes/environment)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Neutral curriculum focusing on alcohol use in young people
Number of subjects: 159
Study: 17891547

Group type: EXPERIMENTAL
Intervention: Standard care plus music imagery (twice weekly for up to eight sessions)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 78
Study: 16173852

Group type: EXPERIMENTAL
Intervention: Cognitive group therapy (CT)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Treatment as usual (including continuation of pharmacotherapy)
Number of subjects: 187
Study: 12502654

Group type: EXPERIMENTAL
Intervention: Community-based nutrition and exercise intervention (11 weekly nutrition classes, triweekly walking groups)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (basic diabetes education only)
Number of subjects: 75
Study: 10374096

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 23

Group type: COMPARATOR
Intervention: In-vitro fertilization (IVF)
Number of subjects: 23
Study: 8911161

Group type: EXPERIMENTAL
Intervention: HASTE MR urography
Number of subjects: 56
Study: 1650266

Group type: EXPERIMENTAL
Intervention: vindesine + cisplatin
Number of subjects: 46

Group type: COMPARATOR
Intervention: best supportive care
Number of subjects: 46
Study: 7081117

Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE)
Number of subjects: 10
Study: 28982740

Group type: EXPERIMENTAL
Intervention: PF-00547659 22.5 mg
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: PF-00547659 75 mg
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: PF-00547659 225 mg
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: PF-00547659
Number of subjects: 265
Study: 26991464

Group type: EXPERIMENTAL
Intervention: Cytology combined with HPV16/18 genotyping
Number of subjects: 520

Group type: COMPARATOR
Intervention: Cytology with a threshold of ASC-US
Number of subjects: 520
Study: 25102847

Group type: EXPERIMENTAL
Intervention: Community and school-based events incorporating an animated film, skits, and public pledging ceremonies.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Shortened version of the intervention (received by control villages before the final follow-up round).
Number of subjects: 14
Study: 22785143

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study: 20031284

Group type: EXPERIMENTAL
Intervention: Lugol's iodine group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard group
Number of subjects: 100
Study: 18696359

Group type: EXPERIMENTAL
Intervention: Home blood pressure (HBP) monitoring
Number of subjects: 57
Study: 15522899

Group type: EXPERIMENTAL
Intervention: Sodium ferric gluconate 125 mg infused over 1 h
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium ferric gluconate 250 mg infused over 2 h
Number of subjects: 8

Group type: COMPARATOR
Intervention: N-acetylcysteine (NAC) pre-treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo pre-treatment
Number of subjects: 8
Study: 12413432

Group type: EXPERIMENTAL
Intervention: Varicella-zoster hyperimmune globulin (VZV-IG) 2mL/kg body weight
Number of subjects: 40

Group type: COMPARATOR
Intervention: Human albumin 5% 2mL/kg body weight (Control group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: McGill Pain-Rating Questionnaire
Number of subjects: 40

Group type: COMPARATOR
Intervention: Revised Multidimensional Pain Scale (RMSS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Freiburg symptom list (FBL)
Number of subjects: 40
Study: 10220271

Group type: EXPERIMENTAL
Intervention: Plateletpheresis using AMICUS
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Plateletpheresis using MCS 3p
Number of subjects: 26

Group type: COMPARATOR
Intervention: Infusion of ACD-A
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 26
Study: 8521710

Group type: EXPERIMENTAL
Intervention: TCu 380A IUD
Number of subjects: 710

Group type: COMPARATOR
Intervention: Lippes Loop IUD
Number of subjects: 710
Study: 2196353

Group type: EXPERIMENTAL
Intervention: Furosemide, 4 mg/kg in two divided doses on alternate days orally for 8 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo for 8 days
Number of subjects: 11
Study: 357451

Group type: EXPERIMENTAL
Intervention: Cue-controlled relaxation therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 28
Study: 30136879

Group type: EXPERIMENTAL
Intervention: Web-based intervention (Bounce Back Now - BBN)
Number of subjects: 979
Study: 31536511

Group type: EXPERIMENTAL
Intervention: Silymarin 700 mg
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Silymarin 420 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 27175783

Group type: EXPERIMENTAL
Intervention: Gain-framed conditions (certain outcome)
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Loss-framed conditions (uncertain outcome)
Number of subjects: 1300
Study: 26046796

Group type: EXPERIMENTAL
Intervention: gemcitabine plus erlotinib
Number of subjects: 88

Group type: COMPARATOR
Intervention: gemcitabine
Number of subjects: 88
Study: 24093487

Group type: EXPERIMENTAL
Intervention: Very-low-density lipoprotein (VLDL) cholesterol level
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cholesterol proportions in large VLDLs (Fraction 4)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cholesterol proportions in large VLDLs (Fraction 5)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cholesterol proportions in medium VLDL (Fraction 6)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Size of VLDL particles
Number of subjects: 35
Study: 21855758

Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1%
Number of subjects: 59

Group type: COMPARATOR
Intervention: Fluorometholone 0.1%
Number of subjects: 59
Study: 19675477

Group type: EXPERIMENTAL
Intervention: Hydrated (HYR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Dehydrated (DHR)
Number of subjects: 17
Study: 17960967

Group type: EXPERIMENTAL
Intervention: Active rTMS (N = 6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham stimulation (N = 5)
Number of subjects: 11
Study: 15483018

Group type: EXPERIMENTAL
Intervention: Combined-modality therapy including cyclophosphamide, doxorubicin, methotrexate, fluorouracil, leucovorin, hormonal synchronization with conjugated estrogens and tamoxifen, followed by definitive radiotherapy or mastectomy and adjuvant chemotherapy.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Combined-modality therapy for stage IIIA breast cancer patients.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Combined-modality therapy for stage IIIB non-IBC patients.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Combined-modality therapy for IBC patients.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Pathologic response in stage IIIA or IBC patients.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Presence of dermal lymphatic invasion in clinical IBC patients.
Number of subjects: 107
Study: 11157314

Group type: EXPERIMENTAL
Intervention: Stearic acid (1 g fat/kg body wt)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Palmitic acid (1 g fat/kg body wt)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Unsaturated fatty acids (1 g fat/kg body wt)
Number of subjects: 16
Study: 9436720

Group type: EXPERIMENTAL
Intervention: Dysport (mean dose: 477 units)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Botox (mean dose: 152 units)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Dysport
Number of subjects: 73

Group type: COMPARATOR
Intervention: Botox
Number of subjects: 73
Study: 8615058

Group type: EXPERIMENTAL
Intervention: 1 alpha, 24 dihydroxyvitamin D3 ointment (4 micrograms/g applied once daily) for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1 alpha, 24 dihydroxyvitamin D3 ointment and Placebo
Number of subjects: 20
Study: 2653461

Group type: EXPERIMENTAL
Intervention: Methotrexate and cyclosporine (n = 43)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cyclosporine alone (n = 50)
Number of subjects: 93
Study: 788750

Group type: EXPERIMENTAL
Intervention: Prorenoate potassium (40 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Spironolactone (100 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31617739

Group type: EXPERIMENTAL
Intervention: Water deprivation (WD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Euhydration control condition (CON)
Number of subjects: 35
Study: 31064967

Group type: EXPERIMENTAL
Intervention: Reinforcement program for behavioral skills in postpartum care
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 28167176

Group type: EXPERIMENTAL
Intervention: Foam Roll Group (FMG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo Group (PG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study: 25998877

Group type: EXPERIMENTAL
Intervention: Ready for Child program
Number of subjects: 1193

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1193
Study: 24102851

Group type: EXPERIMENTAL
Intervention: Simultaneous blood pressure measurement
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sequential blood pressure measurement
Number of subjects: 240
Study: 21211729

Group type: EXPERIMENTAL
Intervention: leuproreline 11,25 mg for 3 years
Number of subjects: 264

Group type: COMPARATOR
Intervention: radiotherapy plus leuproreline 11,25 mg for 3 years
Number of subjects: 264
Study: 19925286

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.75 mg/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nadroparin (70.4 IU/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dalteparin (78.6 IU/kg)
Number of subjects: 17
Study: 16936950

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with amniotic membrane (study group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard trabeculectomy without amniotic membrane (control group)
Number of subjects: 32
Study: 14609603

Group type: EXPERIMENTAL
Intervention: Bare metal stenting
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Atherectomy before stenting
Number of subjects: 412
Study: 10356097

Group type: EXPERIMENTAL
Intervention: Patching
Number of subjects: 74

Group type: COMPARATOR
Intervention: PC
Number of subjects: 74
Study: 8832603

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2006593

Group type: EXPERIMENTAL
Intervention: 2 mg IVB
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: 2 mg TNB
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: 1 mg TNB followed by 1 mg TNB at 60 min
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: 0.5 mg TNB followed by 0.5 mg TNB at 60 min
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: 1 mg TNB (divided into 2 doses)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Multiple doses of TNB and IVB
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 186
Study: 7082535

Group type: EXPERIMENTAL
Intervention: Domperidone (20 mg) i.v.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline i.v.
Number of subjects: 6
Study: 6330773

Group type: EXPERIMENTAL
Intervention: High frequency/low intensity (HiF/Lol) TENS for 30 minutes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low frequency/high density (LoF/Hil) TENS for 30 minutes
Number of subjects: 31

Group type: COMPARATOR
Intervention: No stimulation (placebo)
Number of subjects: 31
Study: 29171086

Group type: EXPERIMENTAL
Intervention: Intracoronary prourokinase (IP)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 230
Study: 25810068

Group type: EXPERIMENTAL
Intervention: darbepoetin alfa treatment
Number of subjects: 4038
Study: 24885192

Group type: EXPERIMENTAL
Intervention: Educational intervention for patients or their caregivers
Number of subjects: 345
Study: 23257490

Group type: EXPERIMENTAL
Intervention: Lycopene (8 mg Lycored TM per day in two divided doses of 4 mg each)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (placebo tablet twice a day)
Number of subjects: 92
Study: 20967981

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1 intramuscular injection)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Vardenafil (on-demand monotherapy for 6 weeks)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined treatment (testosterone undecanoate and vardenafil in the same doses and duration)
Number of subjects: 96
Study: 18369200

Group type: EXPERIMENTAL
Intervention: Stimulus 1: maximal eucapnic voluntary hyperpnea against inspiratory resistance
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Stimulus 2: Pet(CO(2)) 6.1 mm Hg above resting with ventilation restriction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Stimulus 3: Pet(CO(2)) 7.7 mm Hg above resting with further ventilation restriction
Number of subjects: 12
Study: 15857093

Group type: EXPERIMENTAL
Intervention: Implants in patients with generalized aggressive periodontitis (GAgP)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Implants in patients with generalized chronic periodontitis (GCP)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Implants in periodontally healthy patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Teeth and implants in patients with generalized aggressive periodontitis (GAgP)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Teeth and implants in patients with generalized chronic periodontitis (GCP)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Teeth and implants in periodontally healthy patients
Number of subjects: 39
Study: 12055814

Group type: EXPERIMENTAL
Intervention: Mebendazole 500 mg
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 10606129

Group type: EXPERIMENTAL
Intervention: Community-based family nursing clinical rotations
Number of subjects: 137
Study: 7567418

Group type: EXPERIMENTAL
Intervention: SHORT‐F condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LONG‐F condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task repetition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Muscle testing of 'Weak' or 'Strong'
Number of subjects: 0
Study: 2031518

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 231
Study: 7247083

Group type: EXPERIMENTAL
Intervention: MAP card
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 30764560

Group type: EXPERIMENTAL
Intervention: High-protein meal (HP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-carbohydrate meal (HCHO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of OB vs. HW
Number of subjects: 20
Study: 29208251

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 75
Study: 25684087

Group type: EXPERIMENTAL
Intervention: Device servo‐regulated cooling
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard practice (control)
Number of subjects: 100
Study: 25008206

Group type: EXPERIMENTAL
Intervention: 12-week exercise intervention (group- and home-based)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 130
Study: 22390266

Group type: EXPERIMENTAL
Intervention: 10‐min intervention designed to reframe metacognitive interpretation of difficulty
Number of subjects: 310

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 310
Study: 19769793

Group type: EXPERIMENTAL
Intervention: Intensified diet and physical activity
Number of subjects: 507

Group type: COMPARATOR
Intervention: Conventional care control
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Haploblock including variants rs659366, rs653529, rs15763, and rs1726745
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Haplotype comprising alleles rs659366-G, rs653529-A, rs15763-G and rs1726745-A
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Haplotype comprising alleles rs3781907-G, rs11235972-A, and rs1800849-T
Number of subjects: 507
Study: 17558361

Group type: EXPERIMENTAL
Intervention: Hippotherapy intervention for 14 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Final BBS scores comparison
Number of subjects: 15
Study: 15675259

Group type: EXPERIMENTAL
Intervention: Intranasal sufentanil 20 microg and intranasal midazolam 0.3 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intranasal ketamine 5 mg/kg and intranasal midazolam 0.3 mg/kg
Number of subjects: 50